Advancements in colorectal surgery have transformed the prognosis for patients diagnosed with rectal cancer. One such innovation is the transanal total mesorectal excision (TaTME), which has been gaining traction as a viable surgical approach since its introduction in 2010. A compelling case reported in “Chirurgia (Bucharest, Romania: 1990)” exemplifies the promise this technique holds for the future of rectal cancer treatments.

Case Report Overview

In this seminal case report published in the March-April 2019 issue of “Chirurgia,” experts Tudor Ștefan, Minciună Corina, Lăcătuș Monica, Gavrilă Daniel, Manciu Simona, Ungureanu Daniela, Cordun Mihai, and Vasilescu Cătălin detail the procedure and outcomes for a 65-year-old patient diagnosed with a moderately differentiated adenocarcinoma of the middle rectum, staged cT2N0M0. Given the characteristics of the patient and the tumor features, the clinical team made the call to employ the TaTME technique for this particular case.

The article, which can be found with the DOI: 10.21614/chirurgia.114.2.278, thoroughly discusses the surgical process, potential postoperative complications, and oncological considerations. It underscores the necessity for selecting the right patients and the value of extensive proficiency in minimally invasive colorectal surgery for optimal application of the technique.

Transanal Total Mesorectal Excision Technique

TaTME is characterized by a bottom-up approach to the removal of cancerous tissue within the rectum. It presents an alternative to the traditional laparoscopic total mesorectal excision (laTME), which is a top-down method. TaTME is believed to offer surgeons better visualization and access to the lower part of the rectum, which can be invaluable for patients with difficult anatomical constraints or advanced tumoral stages.

The procedure involves using specialized transanal endoscopic equipment to access and remove the entire mesorectum – the fatty tissue surrounding the rectum – which is essential for ensuring clear margins and reducing the risk of local recurrence. The method’s evolution is a promising sign for minimally invasive surgeries, and its potential to be a gold-standard approach is under active investigation.

Discussion on Results and Implications

The case report in “Chirurgia” analyses the feasibility of TaTME and its treatment efficacy. The patient recovered with satisfactory outcomes and no immediate complications. Though the case study is promising, the authors advocate for judicious patient selection and caution that only surgeons with extensive backgrounds in minimally invasive colorectal procedures should attempt TaTME, given its complexity and learning curve.

This article contributes valuable insights into the ongoing debate regarding the superiority of TaTME over laTME. While some studies suggest improved outcomes with TaTME, particularly for low rectal tumors, the authors rightfully assert that more in-depth, randomized controlled trials are necessary to establish definitive conclusions.


1. Transanal Total Mesorectal Excision
2. TaTME for rectal cancer
3. Minimally invasive colorectal surgery
4. Rectal adenocarcinoma treatment
5. Surgical advancements in rectal cancer


1. Tudor Ștefan, et al. (2019). Transanal Total Mesorectal Excision – A Case Report. Chirurgia (Bucharest, Romania: 1990), 114(2), 278-283. DOI: 10.21614/chirurgia.114.2.278

2. Atallah, S., Albert, M., & Larach, S. (2010). Transanal minimally invasive surgery for total mesorectal excision (TaTME). Tech Coloproctol, 14(3), 221-225. DOI: 10.1007/s10151-010-0622-8

3. Penna, M., Hompes, R., Arnold, S., et al. (2017). Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Annals of Surgery, 266(1), 111-117. DOI: 10.1097/SLA.0000000000001948

4. Veltcamp Helbach, M., Deijen, C. L., Velthuis, S., et al. (2016). Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surgical Endoscopy, 30(11), 4835-4843. DOI: 10.1007/s00464-016-4844-0

5. Simillis, C., Hompes, R., Penna, M., et al. (2016). A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and transanal endoscopic microsurgery for T1-2 rectal cancer. Colorectal Disease, 18(1), 6-16. DOI: 10.1111/codi.13208


The case report published in “Chirurgia” stands as a testament to the continuous efforts towards surgical innovation in the fight against rectal cancer. While TaTME showcases potential as a ground-breaking procedure, the pathway to establishing its routine application will require a combination of further research, clinical trials, and the development of best-practice protocols. As the landscape of minimally invasive colorectal surgery evolves, so too does the hope for better patient outcomes and quality of life post-surgery.